Login / Signup

EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndrome.

Shengjiang TanLaëtitia KermassonAngela HoslinPekka JaakoAlexandre FailleAbraham Acevedo-ArozenaEtienne LenglineDana RantaMaryline PoiréeOdile FenneteauHubert Ducou le PointeStefano FumagalliBlandine BeaupainPatrick NitschkéChristine Bôle-FeysotJean-Pierre de VillartayChristine Bellanné-ChantelotJean DonadieuCaroline KannengiesserAlan John WarrenPatrick Revy
Published in: Blood (2019)
Shwachman-Diamond syndrome (SDS) is a recessive disorder typified by bone marrow failure and predisposition to hematological malignancies. SDS is predominantly caused by deficiency of the allosteric regulator Shwachman-Bodian-Diamond syndrome that cooperates with elongation factor-like GTPase 1 (EFL1) to catalyze release of the ribosome antiassociation factor eIF6 and activate translation. Here, we report biallelic mutations in EFL1 in 3 unrelated individuals with clinical features of SDS. Cellular defects in these individuals include impaired ribosomal subunit joining and attenuated global protein translation as a consequence of defective eIF6 eviction. In mice, Efl1 deficiency recapitulates key aspects of the SDS phenotype. By identifying biallelic EFL1 mutations in SDS, we define this leukemia predisposition disorder as a ribosomopathy that is caused by corruption of a fundamental, conserved mechanism, which licenses entry of the large ribosomal subunit into translation.
Keyphrases
  • bone marrow
  • intellectual disability
  • case report
  • mesenchymal stem cells
  • small molecule
  • type diabetes
  • dna repair
  • skeletal muscle
  • adipose tissue
  • amino acid
  • smoking cessation
  • structural basis